Researchers apply SLU-PP-332 to investigate its selective activation of ERR isoforms without estrogen receptor involvement, inducing gene programs that mimic endurance exercise adaptations. Pre-clinical findings in rodent models of obesity and inactivity indicate increased mitochondrial respiration, elevated energy expenditure, and improved metabolic flexibility through enhanced fat oxidation.
This small molecule facilitates examination of ERR-dependent transcriptional networks, PGC-1α coactivation, and systemic metabolic shifts in sedentary or disease-associated research paradigms.
Scientific Overview of SLU-PP-332 Applications
Pre-clinical models demonstrate SLU-PP-332’s engagement with ERR-related mechanisms:
- Potent pan-ERR agonism (EC₅₀ ≈ 98 nM ERRα) activating aerobic exercise gene programs and mitochondrial biogenesis in skeletal muscle and adipose tissue. https://pubmed.ncbi.nlm.nih.gov/37739806/
- Elevation of energy expenditure and fatty acid oxidation, leading to significant reductions in fat mass and body weight in diet-induced obese rodent models.
- Improvement of insulin sensitivity and glucose tolerance without altering food intake or lean mass in metabolic syndrome paradigms.
- Induction of endurance-like performance enhancements in sedentary animals, including increased running capacity and mitochondrial function.
- Support for investigations into ERR-mediated metabolic reprogramming in obesity, type 2 diabetes, and NAFLD-related models.
- Examination of mitochondrial respiration and PGC-1α-dependent pathways in muscle and liver tissue under inactivity or stress conditions.
For further details on estrogen-related receptor agonists, mitochondrial biogenesis, and exercise-mimetic signaling in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Why Investigators Select National Science Labs SLU-PP-332
National Science Labs manufactures SLU-PP-332 under rigorous GMP-compliant protocols to ensure batch-to-batch consistency and reliability for pre-clinical experiments. Independent third-party testing verifies each lot for:
- Purity ≥99.9% by HPLC
- Structural identity confirmation via mass spectrometry
- Complete Certificate of Analysis (CoA) documentation provided per batch
For Research Use Only. This product is supplied exclusively for in vitro and in vivo pre-clinical research by qualified investigators. Statements about this compound have not been evaluated by the FDA.
Initiate Your SLU-PP-332 Research Protocol
Source high-purity SLU-PP-332 from current limited batches to ensure optimal stability and performance in ERR agonism and exercise-mimetic studies.
